The past year for MacroGenics (NASDAQ:MGNX) investors has not been profitable

Published on 17 Feb 2025 on Simply Wall St. · via Yahoo Finance

Even the best investor on earth makes unsuccessful investments. But it should be a priority to avoid...

Read the rest of the article

Start tracking your investments with Statfolio

Even the best investor on earth makes unsuccessful investments. But it should be a priority to av...

Simply Wall St. · via Yahoo Finance 17 Feb 2025

Macrogenics Inc (MGNX) reports a remarkable revenue increase driven by milestone payments, while...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

Macrogenics Inc (NASDAQ:MGNX) is set to release its Q3 2024 earnings on Nov 5, 2024. The consensu...

GuruFocus.com · via Yahoo Finance 4 Nov 2024

This month, we saw the MacroGenics, Inc. (NASDAQ:MGNX) up an impressive 37%. But that doesn't cha...

Simply Wall St. · via Yahoo Finance 20 Jun 2024

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.32%

Investing.com 10 May 2024

MacroGenics, Inc. (NASDAQ: NASDAQ:MGNX), a biopharmaceutical company specializing in the developm...

Investing.com 10 May 2024

On Thursday, MacroGenics Inc MGNX released interim data from the TAMARACK Phase 2 study of vobram...

Benzinga 10 May 2024

MacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript May 10, 2024 MacroGenics, Inc. i...

Insider Monkey via Yahoo Finance 10 May 2024

After-hours movers: Akamai Technologies, Unity, Macrogenics and more

Investing.com 9 May 2024

Stuart Peters, Senior VP and General Counsel at MacroGenics Inc (NASDAQ:MGNX), sold a significant...

Investing.com 9 Apr 2024